 Vijaya Vemulakonda
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urologic Surgical Procedures | 12 | 2021 | 89 | 4.460 |
Why?
| | Ureteral Obstruction | 6 | 2021 | 58 | 4.000 |
Why?
| | Hydronephrosis | 6 | 2021 | 33 | 3.210 |
Why?
| | Urology | 6 | 2019 | 46 | 2.390 |
Why?
| | Kidney Pelvis | 3 | 2021 | 22 | 1.980 |
Why?
| | Urethral Diseases | 3 | 2022 | 15 | 1.200 |
Why?
| | Pediatrics | 4 | 2019 | 1053 | 1.200 |
Why?
| | Urinary Bladder | 4 | 2016 | 150 | 1.120 |
Why?
| | Urologists | 2 | 2020 | 15 | 0.960 |
Why?
| | Infant | 19 | 2021 | 8097 | 0.960 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.960 |
Why?
| | Urinary Tract | 1 | 2022 | 31 | 0.940 |
Why?
| | Electronic Health Records | 4 | 2019 | 692 | 0.910 |
Why?
| | Qualitative Research | 5 | 2022 | 819 | 0.900 |
Why?
| | Urologic Diseases | 3 | 2018 | 38 | 0.870 |
Why?
| | Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.860 |
Why?
| | Kidney Transplantation | 2 | 2022 | 520 | 0.860 |
Why?
| | Kidney Diseases, Cystic | 1 | 2020 | 19 | 0.850 |
Why?
| | Renal Insufficiency | 1 | 2022 | 130 | 0.830 |
Why?
| | Fetal Diseases | 1 | 2022 | 177 | 0.830 |
Why?
| | Hypospadias | 2 | 2018 | 25 | 0.830 |
Why?
| | Biomedical Research | 2 | 2018 | 585 | 0.800 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1241 | 0.740 |
Why?
| | Neurotoxicity Syndromes | 1 | 2018 | 16 | 0.730 |
Why?
| | Fasting | 1 | 2020 | 264 | 0.720 |
Why?
| | Stakeholder Participation | 1 | 2019 | 67 | 0.710 |
Why?
| | Urinary Tract Infections | 2 | 2018 | 126 | 0.710 |
Why?
| | Urinary Incontinence | 2 | 2016 | 56 | 0.710 |
Why?
| | Postnatal Care | 2 | 2015 | 71 | 0.690 |
Why?
| | Outpatients | 1 | 2020 | 263 | 0.690 |
Why?
| | Urinary Fistula | 1 | 2017 | 6 | 0.680 |
Why?
| | Preoperative Care | 1 | 2020 | 339 | 0.680 |
Why?
| | Anesthesia | 1 | 2018 | 86 | 0.670 |
Why?
| | Prenatal Diagnosis | 2 | 2020 | 163 | 0.660 |
Why?
| | Spinal Dysraphism | 2 | 2017 | 31 | 0.640 |
Why?
| | Epispadias | 1 | 2016 | 4 | 0.640 |
Why?
| | Bladder Exstrophy | 1 | 2016 | 17 | 0.630 |
Why?
| | Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.630 |
Why?
| | Urogenital System | 1 | 2016 | 13 | 0.630 |
Why?
| | Ultrasonography, Prenatal | 4 | 2022 | 247 | 0.620 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 279 | 0.620 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2016 | 3 | 0.620 |
Why?
| | Kidney Failure, Chronic | 1 | 2022 | 502 | 0.610 |
Why?
| | Child | 24 | 2022 | 17860 | 0.610 |
Why?
| | Kidney | 3 | 2021 | 1197 | 0.610 |
Why?
| | Vesico-Ureteral Reflux | 2 | 2020 | 18 | 0.600 |
Why?
| | Urinary Bladder, Neurogenic | 4 | 2022 | 25 | 0.600 |
Why?
| | Appointments and Schedules | 2 | 2014 | 71 | 0.590 |
Why?
| | Parents | 2 | 2020 | 1149 | 0.580 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2008 | 191 | 0.570 |
Why?
| | Humans | 43 | 2022 | 114578 | 0.560 |
Why?
| | Hernia, Umbilical | 1 | 2014 | 6 | 0.540 |
Why?
| | Risk Assessment | 4 | 2018 | 3208 | 0.530 |
Why?
| | Anus, Imperforate | 1 | 2014 | 21 | 0.520 |
Why?
| | Urogenital Abnormalities | 1 | 2014 | 38 | 0.510 |
Why?
| | Urethra | 1 | 2014 | 49 | 0.510 |
Why?
| | Child, Preschool | 14 | 2020 | 9651 | 0.490 |
Why?
| | Wilms Tumor | 1 | 2013 | 64 | 0.480 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2012 | 41 | 0.470 |
Why?
| | Tumor Burden | 1 | 2013 | 288 | 0.470 |
Why?
| | Referral and Consultation | 1 | 2017 | 648 | 0.470 |
Why?
| | Physicians | 1 | 2020 | 727 | 0.470 |
Why?
| | Retrospective Studies | 14 | 2019 | 11642 | 0.450 |
Why?
| | Female | 27 | 2022 | 63070 | 0.450 |
Why?
| | Botulinum Toxins, Type A | 3 | 2011 | 44 | 0.440 |
Why?
| | Scoliosis | 1 | 2014 | 177 | 0.440 |
Why?
| | Patient Selection | 1 | 2015 | 707 | 0.430 |
Why?
| | Decision Making | 1 | 2018 | 799 | 0.430 |
Why?
| | Data Collection | 1 | 2014 | 677 | 0.430 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1159 | 0.400 |
Why?
| | Infant, Newborn | 7 | 2022 | 5045 | 0.400 |
Why?
| | Male | 26 | 2022 | 60818 | 0.390 |
Why?
| | Tertiary Care Centers | 3 | 2019 | 129 | 0.380 |
Why?
| | Dextrans | 1 | 2009 | 81 | 0.370 |
Why?
| | Cystitis | 2 | 2005 | 23 | 0.360 |
Why?
| | Prune Belly Syndrome | 1 | 2007 | 9 | 0.350 |
Why?
| | Ultrasonography | 3 | 2021 | 783 | 0.340 |
Why?
| | Cultural Diversity | 1 | 2008 | 52 | 0.340 |
Why?
| | Internship and Residency | 2 | 2008 | 987 | 0.340 |
Why?
| | Ethics, Professional | 1 | 2007 | 19 | 0.340 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 183 | 0.330 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 73 | 0.330 |
Why?
| | Diurnal Enuresis | 1 | 2006 | 1 | 0.330 |
Why?
| | Competency-Based Education | 1 | 2007 | 64 | 0.320 |
Why?
| | Follow-Up Studies | 6 | 2019 | 4950 | 0.310 |
Why?
| | Professional Competence | 1 | 2007 | 101 | 0.310 |
Why?
| | Adenoma | 1 | 2007 | 185 | 0.300 |
Why?
| | Pregnancy | 3 | 2022 | 5267 | 0.290 |
Why?
| | Biocompatible Materials | 1 | 2009 | 368 | 0.290 |
Why?
| | Reconstructive Surgical Procedures | 2 | 2018 | 253 | 0.270 |
Why?
| | Neuromuscular Agents | 1 | 2005 | 31 | 0.270 |
Why?
| | Education, Medical, Graduate | 1 | 2008 | 397 | 0.260 |
Why?
| | Postoperative Complications | 4 | 2020 | 2181 | 0.260 |
Why?
| | Incidence | 3 | 2018 | 2454 | 0.240 |
Why?
| | Prospective Studies | 4 | 2020 | 6288 | 0.240 |
Why?
| | Sexual Development | 1 | 2022 | 12 | 0.230 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 805 | 0.230 |
Why?
| | Postoperative Period | 2 | 2020 | 310 | 0.230 |
Why?
| | Urination | 3 | 2014 | 39 | 0.230 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 63 | 0.220 |
Why?
| | Registries | 2 | 2022 | 1915 | 0.220 |
Why?
| | Urography | 2 | 2014 | 10 | 0.220 |
Why?
| | Adolescent | 9 | 2022 | 18658 | 0.220 |
Why?
| | Adenocarcinoma | 1 | 2008 | 808 | 0.210 |
Why?
| | Clinical Competence | 1 | 2008 | 935 | 0.210 |
Why?
| | Patient Portals | 1 | 2019 | 30 | 0.190 |
Why?
| | Bacteriuria | 1 | 2018 | 7 | 0.180 |
Why?
| | User-Computer Interface | 1 | 2019 | 145 | 0.180 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2018 | 24 | 0.180 |
Why?
| | Disorders of Sex Development | 1 | 2018 | 34 | 0.170 |
Why?
| | Renal Dialysis | 1 | 2022 | 369 | 0.170 |
Why?
| | Social Support | 1 | 2022 | 552 | 0.170 |
Why?
| | Cystostomy | 1 | 2017 | 9 | 0.170 |
Why?
| | Cohort Studies | 3 | 2017 | 5000 | 0.170 |
Why?
| | United States | 5 | 2020 | 12551 | 0.170 |
Why?
| | Treatment Outcome | 4 | 2021 | 9190 | 0.160 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 497 | 0.160 |
Why?
| | Perioperative Care | 1 | 2018 | 128 | 0.160 |
Why?
| | Fetus | 1 | 2020 | 653 | 0.160 |
Why?
| | Analgesia | 1 | 2017 | 98 | 0.160 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 14 | 0.160 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4741 | 0.150 |
Why?
| | Reoperation | 1 | 2018 | 546 | 0.150 |
Why?
| | Caregivers | 1 | 2022 | 655 | 0.150 |
Why?
| | Global Health | 1 | 2018 | 346 | 0.150 |
Why?
| | Risk Factors | 5 | 2018 | 9078 | 0.140 |
Why?
| | General Surgery | 1 | 2016 | 141 | 0.140 |
Why?
| | Databases, Factual | 2 | 2017 | 1161 | 0.140 |
Why?
| | Health Information Exchange | 1 | 2014 | 17 | 0.130 |
Why?
| | Adult | 6 | 2022 | 32077 | 0.130 |
Why?
| | Recovery of Function | 1 | 2018 | 615 | 0.130 |
Why?
| | ROC Curve | 1 | 2015 | 489 | 0.130 |
Why?
| | Cloaca | 1 | 2014 | 48 | 0.130 |
Why?
| | Age Factors | 3 | 2018 | 3280 | 0.120 |
Why?
| | Program Evaluation | 2 | 2008 | 875 | 0.120 |
Why?
| | Cystoscopy | 2 | 2011 | 18 | 0.110 |
Why?
| | Feasibility Studies | 1 | 2014 | 749 | 0.110 |
Why?
| | Urinary Retention | 1 | 2011 | 19 | 0.110 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 295 | 0.110 |
Why?
| | Sex Factors | 3 | 2018 | 1971 | 0.100 |
Why?
| | Ureteroscopy | 1 | 2009 | 14 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2847 | 0.090 |
Why?
| | Patient Compliance | 1 | 2014 | 609 | 0.090 |
Why?
| | Length of Stay | 2 | 2018 | 1071 | 0.090 |
Why?
| | Injections | 1 | 2009 | 167 | 0.090 |
Why?
| | Electrocoagulation | 1 | 2007 | 33 | 0.090 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 131 | 0.080 |
Why?
| | Stomach | 1 | 2008 | 94 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2926 | 0.080 |
Why?
| | Medical Staff, Hospital | 1 | 2007 | 78 | 0.080 |
Why?
| | Educational Measurement | 1 | 2008 | 298 | 0.070 |
Why?
| | Urothelium | 1 | 2005 | 31 | 0.070 |
Why?
| | Professional Role | 1 | 2007 | 165 | 0.070 |
Why?
| | Administration, Intravesical | 1 | 2005 | 12 | 0.070 |
Why?
| | Program Development | 1 | 2007 | 369 | 0.070 |
Why?
| | Faculty, Medical | 1 | 2007 | 246 | 0.070 |
Why?
| | Laparoscopy | 1 | 2008 | 395 | 0.070 |
Why?
| | Biopsy | 1 | 2007 | 1049 | 0.070 |
Why?
| | Phimosis | 1 | 2003 | 1 | 0.060 |
Why?
| | Colorado | 1 | 2014 | 4488 | 0.060 |
Why?
| | Circumcision, Male | 1 | 2003 | 13 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3485 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2379 | 0.060 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 464 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3145 | 0.060 |
Why?
| | Disease Management | 1 | 2006 | 605 | 0.060 |
Why?
| | Chronic Disease | 2 | 2005 | 1649 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2970 | 0.060 |
Why?
| | Urolithiasis | 1 | 2018 | 7 | 0.050 |
Why?
| | Cryptorchidism | 1 | 2018 | 11 | 0.050 |
Why?
| | Rats | 2 | 2005 | 6201 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2018 | 56 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 84 | 0.040 |
Why?
| | Urine | 1 | 2018 | 62 | 0.040 |
Why?
| | Constipation | 1 | 2018 | 69 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1600 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 113 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 947 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2051 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2011 | 32 | 0.030 |
Why?
| | Quality of Life | 1 | 2022 | 2230 | 0.030 |
Why?
| | Urodynamics | 1 | 2011 | 31 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2018 | 3249 | 0.030 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2011 | 44 | 0.030 |
Why?
| | Prognosis | 1 | 2018 | 3546 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2011 | 243 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1004 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2011 | 284 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1217 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2005 | 10 | 0.020 |
Why?
| | Mechanoreceptors | 1 | 2005 | 15 | 0.020 |
Why?
| | Young Adult | 1 | 2022 | 10987 | 0.020 |
Why?
| | Animals | 2 | 2005 | 34690 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2005 | 38 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7029 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2005 | 111 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2005 | 232 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2005 | 140 | 0.020 |
Why?
| | Sensory Receptor Cells | 1 | 2005 | 85 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2005 | 430 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2003 | 461 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2005 | 3828 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|